JAK/STAT Signaling
JAK/STAT Signaling(JAK/STAT 信号通路)
JAK/STAT Signaling 相关产品(544)
- GC31660Delgocitinib (JTE-052)CAS: 1263774-59-9纯度: >99.50%
Delgocitinib (JTE-052) (JTE-052) 是一种特异性 JAK 抑制剂,对 JAK1、JAK2、JAK3 和 Tyk2 的 IC50 分别为 2.8、2.6、13 和 58 nM。
- GC31677Oclacitinib maleate (PF-03394197 maleate)CAS: 1640292-55-2纯度: >99.50%
A JAK family kinase inhibitor
- GC31866JAK inhibitor 1CAS: 2096999-92-5
JAK inhibitor 1 是从专利 US20170121327A1 化合物实施例 283 中提取的 JAK 抑制剂。
- GC31902JAK3-IN-6CAS: 1443235-95-7纯度: >98.00%
Selective JAK3 inhibitor 1 is an irreversible JAK3 inhibitor with Ki values of 0.07 nM, 320 nM, 740 nM for JAK3, JAK1 and JAK2 respectively. It is also selective over the other kinases possessing a cysteine in the same region as JAK3, such as BMX, EGFR, ITK, and BTK.
- GC32023Abrocitinib (PF-04965842)CAS: 1622902-68-4纯度: >98.00%
Abrocitinib (PF-04965842)是一种口服活性且选择性的Janus激酶(JAK)抑制剂,对JAK1和JAK2的IC 50 值分别为29nM和803nM。
- GC32100Tarloxotinib bromide (TH-4000)CAS: 1636180-98-7纯度: >98.50%
Tarloxotinib bromide (TH-4000)是一种不可逆的EGFR/HER2抑制剂前体。
- GC32733Pyrotinib (SHR-1258)CAS: 1269662-73-8纯度: >99.50%
Pyrotinib (SHR-1258) (SHR-1258) 是一种有效的选择性 EGFR/HER2 双重抑制剂,IC50 分别为 13 和 38 nM。
- GC32809Ilginatinib (NS-018)CAS: 1239358-86-1纯度: >99.00%
Ilginatinib (NS-018) (NS-018) 是一种高活性且具有口服生物利用度的 JAK2 抑制剂,其 IC50 为 0.72 nM,对 JAK2 的选择性是 JAK1 的 46、54 和 31 倍(IC50,33 nM), JAK3 (IC50, 39 nM) 和 Tyk2 (IC50, 22 nM)。
- GC32836Naquotinib mesylate (ASP8273)CAS: 1448237-05-5纯度: >98.00%
An irreversible inhibitor of mutant EGFRs
- GC32862inS3-54A18CAS: 328998-53-4纯度: >99.50%
inS3-54A18 is a potent inhibitor of STAT3 with anti-cancer properties.
- GC32989Pyrotinib dimaleate (SHR-1258 dimaleate)CAS: 1397922-61-0纯度: >98.00%
Pyrotinib (SHR-1258, BLTN, Pyrroltinib) dimaleate is a potent and selective irreversible dual tyrosine kinase inhibitor of EGFR and HER2 with IC50 of 0.013 μM and 0.038 μM, respectively.
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC31659 | Tyk2-IN-4 (BMS-986165) | 1609392-27-9 | >99.50% | |
An allosteric inhibitor of TYK2 | ||||
| GC31660 | Delgocitinib (JTE-052) | 1263774-59-9 | >99.50% | |
Delgocitinib (JTE-052) (JTE-052) 是一种特异性 JAK 抑制剂,对 JAK1、JAK2、JAK3 和 Tyk2 的 IC50 分别为 2.8、2.6、13 和 58 nM。 | ||||
| GC31668 | TYK2-IN-2 | 2098466-94-3 | >99.50% | |
TYK2-IN-2是TYK2的抑制剂,可用于炎症及自身免疫病的研究。 | ||||
| GC31677 | Oclacitinib maleate (PF-03394197 maleate) | 1640292-55-2 | >99.50% | |
A JAK family kinase inhibitor | ||||
| GC31752 | Tesevatinib (XL-647) | 781613-23-8 | >98.00% | |
A multi-kinase inhibitor | ||||
| GC31866 | JAK inhibitor 1 | 2096999-92-5 | - | |
JAK inhibitor 1 是从专利 US20170121327A1 化合物实施例 283 中提取的 JAK 抑制剂。 | ||||
| GC31902 | JAK3-IN-6 | 1443235-95-7 | >98.00% | |
Selective JAK3 inhibitor 1 is an irreversible JAK3 inhibitor with Ki values of 0.07 nM, 320 nM, 740 nM for JAK3, JAK1 and JAK2 respectively. It is also selective over the other kinases possessing a cysteine in the same region as JAK3, such as BMX, EGFR, ITK, and BTK. | ||||
| GC31999 | JAK-IN-1 | 1334673-53-8 | - | |
JAK-IN-1是JAK1/2/3抑制剂,IC50分别为0.26,0.8和3.2nM。JAK-IN-1对JAK3的选择性比JAK1高。 | ||||
| GC32023 | Abrocitinib (PF-04965842) | 1622902-68-4 | >98.00% | |
Abrocitinib (PF-04965842)是一种口服活性且选择性的Janus激酶(JAK)抑制剂,对JAK1和JAK2的IC 50 值分别为29nM和803nM。 | ||||
| GC32028 | BMS-066 | 914946-88-6 | - | |
BMS-066是IKKβ/Tyk2的抑制剂,其IC50值分别为9nM,72nM。 | ||||
| GC32052 | Tyk2-IN-3 | 1779493-12-7 | - | |
Tyk2-IN-3是Tyk2pseudokinase的一个抑制剂,其IC50值为485nM。 | ||||
| GC32100 | Tarloxotinib bromide (TH-4000) | 1636180-98-7 | >98.50% | |
Tarloxotinib bromide (TH-4000)是一种不可逆的EGFR/HER2抑制剂前体。 | ||||
| GC32726 | Tucatinib (Irbinitinib) | 937263-43-9 | >99.00% | |
An inhibitor of HER2 | ||||
| GC32733 | Pyrotinib (SHR-1258) | 1269662-73-8 | >99.50% | |
Pyrotinib (SHR-1258) (SHR-1258) 是一种有效的选择性 EGFR/HER2 双重抑制剂,IC50 分别为 13 和 38 nM。 | ||||
| GC32752 | TAS6417 | 1661854-97-2 | >98.50% | |
TAS6417 (CLN-081, TPC-064) is a novel EGFR inhibitor that targets EGFR exon 20 insertion mutations while sparing wild-type (WT) EGFR. IC50 values ranges from 1.1 ± 0.1 to 8.0 ± 1.1 nmol/L. | ||||
| GC32789 | Mogrol | 88930-15-8 | >99.00% | |
Mogrol是罗汉果甜甙的生物代谢物,能够抑制ERK1/2和STAT3的信号通路,同时能降低CREB的活性,活化AMPK。 | ||||
| GC32807 | HJC0152 hydrochloride | 1420290-99-8 | >98.50% | |
An orally bioavailable inhibitor of STAT3 | ||||
| GC32809 | Ilginatinib (NS-018) | 1239358-86-1 | >99.00% | |
Ilginatinib (NS-018) (NS-018) 是一种高活性且具有口服生物利用度的 JAK2 抑制剂,其 IC50 为 0.72 nM,对 JAK2 的选择性是 JAK1 的 46、54 和 31 倍(IC50,33 nM), JAK3 (IC50, 39 nM) 和 Tyk2 (IC50, 22 nM)。 | ||||
| GC32836 | Naquotinib mesylate (ASP8273) | 1448237-05-5 | >98.00% | |
An irreversible inhibitor of mutant EGFRs | ||||
| GC32862 | inS3-54A18 | 328998-53-4 | >99.50% | |
inS3-54A18 is a potent inhibitor of STAT3 with anti-cancer properties. | ||||
| GC32927 | PF-06459988 | 1428774-45-1 | >99.00% | |
PF-06459988是T790M-ContainingEGFRMutants不可逆性抑制剂。 | ||||
| GC32928 | SH5-07 | 1456632-41-9 | >97.00% | |
SH5-07是一种基于异羟肟酸的Stat3抑制剂,在体外实验中的IC50值为3.9μM。 | ||||
| GC32958 | GDC-0339 | 1428569-85-0 | >99.50% | |
GDC-0339是Pim激酶抑制剂,作用于BaF3PIM1时,IC50为43.6nM。 | ||||
| GC32989 | Pyrotinib dimaleate (SHR-1258 dimaleate) | 1397922-61-0 | >98.00% | |
Pyrotinib (SHR-1258, BLTN, Pyrroltinib) dimaleate is a potent and selective irreversible dual tyrosine kinase inhibitor of EGFR and HER2 with IC50 of 0.013 μM and 0.038 μM, respectively. | ||||
